Periocular Rejuvenation by Topical Hyaluronic Acid Nano Particles
Launched by ALEXANDRIA UNIVERSITY · Feb 14, 2023
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment for improving the appearance of the area around the eyes, specifically targeting issues like dark circles, wrinkles, and tear trough deformities. The researchers want to see if using topical hyaluronic acid nanoparticles—tiny particles applied to the skin—can effectively rejuvenate this delicate area and potentially replace the need for invasive procedures like dermal filler injections.
To participate, you should be a healthy adult between the ages of 21 and 65 who is willing to take part in the study and follow its guidelines, including attending all appointments and allowing your photos to be taken for research purposes. You should also agree not to undergo other treatments in the eye area while in the study. Participants can expect a supportive environment and the chance to contribute to research that could lead to a new, non-invasive way to enhance the appearance of the eyes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Is a healthy male or female between 21 and 65 years old
- • 2. Is voluntarily willing to consent to participate in the study
- • 3. Is willing to comply with all requirements of the study including being photographed, follow post treatment care instructions, to attend all treatment, and follow up visits
- • 4. Willingness to waive rights to use of still photos of themselves for research, marketing, or promotional reasons, including on the internet and on social media outlets.
- • 5. Willingness to refrain from other surgical, laser, or injectable treatments in the periorbital region during the entire duration of the study.
- • 6. Ability to provide informed consent.
- Exclusion Criteria:
- • -
About Alexandria University
Alexandria University, a leading academic institution in Egypt, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise to conduct rigorous studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, Alexandria University aims to contribute to the global body of medical knowledge and enhance the quality of patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alexandria, Elazarita, Egypt
Patients applied
Trial Officials
Yosra S.R Elnaggar, MD
Study Chair
Alexandria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials